Skip to content

Piper Jaffray’s Gitkin Sees Interesting Times Ahead

Andrew Gitkin, head, West Coast biotechnology investment banking, Piper Jaffray, reviews the impact the Trump presidency is having on the public markets. He also hits upon various life sciences indexes and uses the data to project M&A and IPO windows going forward.

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.

Scroll To Top